Prevention of hepatitis development by interferon-alpha in HBV carriers treated with intensive chemotherapy: A pilot study [1]

Annals of Oncology

Volumn 9, Issue 1, 1998, Pages 117-118

  Kumagai, K ^a   Takagi, T ^a   Sakai, C ^a  

^a CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; MITOXANTRONE; VINCRISTINE; VINDESINE;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEPATITIS B; HUMAN; LETTER; LYMPHOMA; MALE; PRIORITY JOURNAL; VIRUS CARRIER;

EID: 0031929862     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008216716778     Document Type: Letter

References (6)

1. Galbraith R.M. Eddleston A.L.W.F. Williams R. Fulminant hepatic failure in leukemia and choriocarcinoma related to withdrawal of cytotoxic drug therapy Lancet ii 1975 528 530
2. Wands J.R. Subacute and chronic active hepatitis after withdrawal of chemotherapy Lancet ii 1975 979 Letter
3. Hoofnagle J.H. Dusheiko G.M. Schafer D.F. Reactivation of chronic hepatitis B virus infection by cancer chemotherapy Ann Intern Med 96 1982 447 449
4. Pinto P.C. Hu E. Bernstein-Singer M. Acute hepatic injury after the withdrawal of immunosuppressive chemotherapy in patients with hepatitis B Cancer 65 1990 878 884
5. Kumagai K. Takagi T. Sakai C. A fatal case of a hepatitis B virus carrier with fulminant hepatic failure after cytotoxic chemotherapy for malignant lymphoma Jpn J Clin Hematol 34 12 1993 1587 1589
6. Kumagai K. Takagi T. Nakamura S. Hepatitis B virus carriers in the treatment of malignant lymphoma: An epidemiological study in Japan Ann Oncol 8 Suppl 1 1997 S107 S109